Your browser doesn't support javascript.
loading
A distinct cutaneous microbiota profile in autoimmune bullous disease patients.
Miodovnik, Mor; Künstner, Axel; Langan, Ewan A; Zillikens, Detlef; Gläser, Regine; Sprecher, Eli; Baines, John F; Schmidt, Enno; Ibrahim, Saleh M.
Afiliação
  • Miodovnik M; Department of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Künstner A; Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany.
  • Langan EA; Max Planck Institute for Evolutionary Biology, Plön, Germany.
  • Zillikens D; Institute of Medical Microbiology und Hygiene, University of Lübeck, Lübeck, Germany.
  • Gläser R; Department of Dermatological Science, Division of Musculoskeletal & Dermatological Sciences, University of Manchester, Manchester, UK.
  • Sprecher E; Department of Dermatology, University of Lübeck, Lübeck, Germany.
  • Baines JF; Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany.
  • Schmidt E; Department of Dermatology, University of Lübeck, Lübeck, Germany.
  • Ibrahim SM; Department of Dermatology, Christian-Albrechts-University of Kiel, Kiel, Germany.
Exp Dermatol ; 26(12): 1221-1227, 2017 12.
Article em En | MEDLINE | ID: mdl-28418589
ABSTRACT
Bullous pemphigoid (BP) is the most common autoimmune blistering disease in Europe. As both the incidence of the disease and the relative proportion of the elderly population continue to rise, it represents a significant medical burden. Whereas some progress has been achieved in defining genetic risk factors for autoimmune blistering diseases, no environmental agent has been conclusively identified. Emerging evidence suggests that host immunity may influence the skin microbiota, while the latter modulates cutaneous immunity. Nevertheless, the relationship between skin microbial communities and autoimmune bullous disease has yet to be studied in humans. Here, we aim to characterise and compare the skin microbiome of patients with BP and healthy, age-matched controls at numerous body sites. Similar to what has been shown in healthy controls, the composition of skin microbiota in patients with BP appears to be very divergent and site specific. Microbial phylum abundances differ between perilesional sites of patients with BP and the same anatomic locations of control patients. A distinct cutaneous microbiota profile, which correlates with BP, further strengthens the significance of commensal-host interaction on our immune system. Moreover, these results raise the possibility that the cutaneous microbiome may contribute to the pathogenesis of BP, with important implications for the treatment of this disease.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pele / Dermatopatias Vesiculobolhosas / Microbiota Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Exp Dermatol Assunto da revista: DERMATOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pele / Dermatopatias Vesiculobolhosas / Microbiota Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Exp Dermatol Assunto da revista: DERMATOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Israel